Vaccines Market Is Projected to Move Ahead at a CAGR of 10.7% by 2030

Vaccines Market Is Projected to Move Ahead at a CAGR of 10.7% by 2030


Global Vaccines Market, By Composition (Combination Vaccines, Monovaccines), Type (Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines, Live-Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, DNA Vaccines), Kind (Routine Vaccine, Recommended Vaccine, Required Vaccine), Age of Administration (Pediatric Vaccine, Adult Vaccine), Diseases (Pneumococcal Disease, Measles, Mumps and Varicella, DPT, Hepatitis, Influenza, Typhoid, Meningococcal, Rabies, Japanese Encephalitis, Yellow Fever, Others), Route of Administration (Injectable, Oral, Nasal), End User (Community Hospitals, Hospitals, Specialty Centres, Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2030.

  • As the number of reported COVID cases increased overall, people worldwide anticipated a vaccine capable of combating the virus. The vaccine market is expected to develop due to the rising demand for coronavirus vaccines. Governments and medical regulators accelerated vaccine development due to the epidemic's severity, even though normal vaccine development needed years to complete the necessary testing. According to the WHO, as of July 27, 2021, there were roughly 108 COVID-19 vaccines in the clinical development stage, 184 vaccines in the pre-clinical development stage, and 21 vaccines had already received approval.
  • Data Bridge Market Research analyses that the vaccines market, which is USD 67.57 billion in 2022, is expected to reach USD 152.39 billion by 2030, at a CAGR of 10.7% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

 Get Sample Details@

 Global Vaccines Market Scope

  • The vaccines market is segmented on the basis of composition, type, kind, age of administration, diseases, route of administration, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.



  • Subunit
  • Recombinant
  • Polysaccharide
  • Conjugate Vaccines
  • Live-Attenuated Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • DNA Vaccines


  • Routine Vaccine
  • Recommended Vaccine
  • Required Vaccine

 Age of Administration

  • Pediatric Vaccine
  • Adult Vaccine


  • Pneumococcal Disease
  • Measles
  • Mumps
  • Varicella
  • DPT
  • Hepatitis
  • Influenza
  • Typhoid
  • Meningococcal
  • Rabies
  • Japanese Encephalitis
  • Yellow Fever
  • Others

 Route of Administration

  • Injectable
  • Oral
  • Nasal

 End User

  • Community Hospitals
  • Hospitals
  • Specialty Centres
  • Clinics
  • Others

 Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

 Vaccines Market Regional Analysis/Insights

  • The countries covered in the vaccines market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

 Competitive Landscape and Vaccines Market Share Analysis

  • The vaccines market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to vaccines market.

Some of the major players operating in the vaccines market are:

  • Merck Co., Inc. (U.S.)
  • Pfizer Inc. (U.S.)
  • GSK plc (U.K.)
  • Sanofi (France)
  • Serum Institute of India Pvt. Ltd. (India)
  • AstraZeneca (U.K.)
  • Johnson Johnson Private Limited (U.S.)
  • Indian Immunologicals Ltd. (India)
  • Novasep (France)
  • MerckKGaA (Germany)
  • Charles River Laboratories (U.K.)
  • uniQure N.V. (Netherlands)
  • Waisman Biomanufacturing (U.S.)
  • Creative-Biogene (U.S.)
  • Aldevron (U.S.)
  • Addgene (U.S.)
  • Oxford Biomedica (U.K.)
  • Thermo Fisher Scientific (U.S.)
  • Fujifilm Corporation (Japan)
  • Spark Therapeutics Inc. (U.S.) 

 Full Access of Report @



Get TOC Details

Explore More Reports:

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475